On the recordFebruary 6, 2018
The FDA has demonstrated that it is best positioned to address specific concerns with the regulation, and this new guidance is an example that FDA is taking the necessary steps to make compliance attainable. Again, we have a new FDA Administrator appointed by the Trump administration, and he is trying to work with industry to get this done. So we shouldn't roll back the clock and undo the progress we have made. Instead, we should be moving forward with the menu labeling requirements as they currently stand and are set to go into effect in May of this year. H.R. 772, unfortunately, would do the opposite; and, for this reason, I oppose the bill and urge my colleagues to oppose the bill as well.
